MERS-Coronavirus Spike antibody (AA 381-505)
Quick Overview for MERS-Coronavirus Spike antibody (AA 381-505) (ABIN6254147)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 381-505
-
Purpose
- Anti-MERSC-CoV Spike Protein
-
Sequence
- VECDFSPLLS GTPPQVYNFK RLVFTNCNYN LTKLLSLFSV NDFTCSQISP AAIASNCYSS LILDYFSYPL SMKSDLSVSS AGPISQFNYK QSFSNPTCLI LATVPHNLTT ITKPLKYSYI NKCSR
-
Specificity
- Detects MERSC-CoV Spike (receptor binding domain) recombinant fusion proteins (MBP-S-protein and GFP-S-protein).
-
Purification
- Epitope affinity purified
-
Immunogen
- Purified recombinant peptide derived from within residues 381-505 aa (Spike receptor binding domain) of Spike protein from Middle East respiratory syndrome coronavirus produced in E. coli.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB:1:500-1:2,000
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS, 20 % glycerol and 0.05 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- The antibody solution should be gently mixed before use.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- For continuous use, store at 2-8 C for one-two days. For extended storage, store in -20 C freezer. Working dilution samples should be discarded if not used within 12 hours.
-
-
- MERS-Coronavirus Spike (MERS-CoV S) (MERS-Coronavirus Spike Protein (MERS-CoV S))
-
Alternative Name
- MERSC-CoV Spike Protein
-
Target Type
- Viral Protein
-
Background
-
Goat polyclonal to Spike protein of Middle East respiratory Syndrome coronavirus. Coronaviruses access host cells by membrane fusion, a process mediated by specific fusion or ""spike"" proteins on the virion, often activated by cellular proteases.
S-protein MERS-CoV antibody.
Target
-